194 related articles for article (PubMed ID: 34889363)
1. What else do I need to worry about when treating graft-versus-host disease?
El-Jawahri A
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):655-661. PubMed ID: 34889363
[TBL] [Abstract][Full Text] [Related]
2. Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease.
Jacobs JM; Fishman S; Sommer R; Sereno I; Fenech A; Jankowski AL; Traeger L; Greer JA; Vanderklish J; Hunnewell C; Saylor M; Chen YB; Spitzer T; DeFilipp Z; Temel JS; El-Jawahri A
Biol Blood Marrow Transplant; 2019 Nov; 25(11):2234-2242. PubMed ID: 31260800
[TBL] [Abstract][Full Text] [Related]
3. "Is this the GVHD?" A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service.
de Vere Hunt I; Kilgour JM; Danby R; Peniket A; Matin RN
Health Qual Life Outcomes; 2021 Jan; 19(1):11. PubMed ID: 33413414
[TBL] [Abstract][Full Text] [Related]
4. Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.
El-Jawahri A; Pidala J; Khera N; Wood WA; Arora M; Carpenter PA; Palmer J; Flowers ME; Jagasia M; Chen YB; Lee SJ
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2285-2292. PubMed ID: 30031937
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
[TBL] [Abstract][Full Text] [Related]
6. Patient-reported symptom burden and impact on daily activities in chronic graft-versus-host disease.
Yu J; Hamilton BK; Turnbull J; Stewart SK; Vernaya A; Bhatt V; Meyers O; Galvin J
Cancer Med; 2023 Feb; 12(3):3623-3633. PubMed ID: 36394207
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review of Patient-Reported Outcome Measures in Graft-versus-Host Disease.
Kilgour JM; Wali G; Gibbons E; Scherwath A; Barata Badiella A; Peniket A; Schoemans H; Matin RN;
Biol Blood Marrow Transplant; 2020 May; 26(5):e113-e127. PubMed ID: 32028026
[TBL] [Abstract][Full Text] [Related]
8. Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.
Hamilton BK; Rybicki L; Arai S; Arora M; Cutler CS; Flowers MED; Jagasia M; Martin PJ; Palmer J; Pidala J; Majhail NS; Lee SJ; Khera N
Biol Blood Marrow Transplant; 2018 Feb; 24(2):393-399. PubMed ID: 29032275
[TBL] [Abstract][Full Text] [Related]
9. Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial.
Nelson AM; Yang D; Jagielo AD; D'Alotto J; Poliquin C; Rabideau DJ; Cronin KG; Newcomb RA; Chen YB; DeFilipp Z; Greer JA; El-Jawahri A; Traeger L
J Natl Compr Canc Netw; 2024 Feb; 22(1):34-42. PubMed ID: 38394783
[TBL] [Abstract][Full Text] [Related]
10. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
Sun YC; Chai X; Inamoto Y; Pidala J; Martin PJ; Flowers ME; Shen TT; Lee SJ; Jagasia M
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1687-91. PubMed ID: 26033283
[TBL] [Abstract][Full Text] [Related]
11. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
[TBL] [Abstract][Full Text] [Related]
12. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
[TBL] [Abstract][Full Text] [Related]
13. Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
Biol Blood Marrow Transplant; 2019 Sep; 25(9):1851-1858. PubMed ID: 31129353
[TBL] [Abstract][Full Text] [Related]
14. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and clinical management of chronic graft-versus-host disease.
Martin PJ; Carpenter PA; Sanders JE; Flowers ME
Int J Hematol; 2004 Apr; 79(3):221-8. PubMed ID: 15168588
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
18. Healthcare resource utilization and costs associated with acute graft-versus-host disease following allogeneic hematopoietic cell transplantation.
Yu J; Lal L; Anderson A; DuCharme M; Parasuraman S; Weisdorf D
Support Care Cancer; 2020 Nov; 28(11):5491-5499. PubMed ID: 32172407
[TBL] [Abstract][Full Text] [Related]
19. Protocol for a feasibility trial (EXPRESS-C-GVHD) for an expressive helping intervention within a support group for cutaneous graft-versus-host-disease.
Kaundinya T; Kye Y; El-Behaedi SE; Choi JN
Arch Dermatol Res; 2023 Dec; 315(10):2905-2912. PubMed ID: 37698591
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-host disease management.
Mistrik M; Bojtarova E; Sopko L; Masakova L; Roziakova L; Martinka J; Batorova A
Bratisl Lek Listy; 2016; 117(7):388-96. PubMed ID: 27546540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
